Skip to main content
SpringerLink
Log in

Assessment of antineoplastic agents by MTT assay: partial underestimation of antiproliferative properties

  • Original Articles
  • MTT Drug Screening Assay, Tumor Cell Lines, Antiproliferative Activity
  • Published:
Cancer Chemotherapy and Pharmacology Aims and scope Submit manuscript

Summary

In the present study a slightly modified MTT assay was used in conjunction with cell counting to determine the antiproliferative efficacy ofN-(2-chloroethyl)-N-nitroso-N′-2-hydroxyethylurea (HECNU), vinblastine, and hexadecylphosphocholine (HPC) in a panel of six tumor cell lines. This panel consisted of two human (MDA-MB231, MCF-7) and two rodent (1/C2, 1/C32) mammary-carcinoma cell lines as well as of two tumor cell lines of gastrointestinal origin (HT-29, KB). It was shown that the use of acid isopropanol as a solvent of the formazan crystals produced correlations between cell number and absorption that were as good as, if not better than, those seen after dimethylsulfoxide (DMSO) application. The optimal period of incubation with the MTT dye was 2 h. A comparison of the antiproliferative activity of HECNU revealed that the HT-29 cell line was most resistant [50% inhibition concentration (IC50), 138.7 μmol/l], followed by MCF-7 cells (IC50, 127.7 μmol/l), whereas MDA-MB231 cells showed the highest sensitivity (IC50, 6 μmol/l). Vinblastine induced the highest (MCF-7 cells; IC50, 0.68 nmol/l) and the lowest (1/C2 cells; IC50, 7.69 nmol/l) degrees of growth inhibition in cell lines derived from mammary carcinoma. This contrasted with the activity of HPC, which was considerably less effective in the four mammary-carcinoma cell lines (IC50 from 29.4 to 69.9 μmol/l) than in the two cell lines of gastrointestinal origin (IC50, 1.9 and 3.1 μmol/l). Interestingly, treatment with HPC stimulated the growth of 1/C32 cells in the lower dose range. After treatment with HECNU, the average IC50 value determined in the MTT assay was 2.4-fold that disclosed by cell counting, whereas the average values found for HPC and vinblastine by both methods corresponded fairly well, with the respective values obtained using the MTT assay being only 26% and 14% higher than those measured by cell counting. A dose-dependent increase in the mean size of MCF-7 cells was observed after exposure to HECNU, which — if taken into account — considerably reduced underestimation of this parameter by the MTT assay. No variation in cell size was noted following treatment with HPC and vinblastine. Thus, depending on the antitumor agent used, the MTT assay can result in slight or even considerable understimation of the antitumor efficacy of certain compounds and may need correction by consideration of the effect of the drugs on cell size.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

Abbreviations

MTT:

3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide

HECNU:

N-(2-ehloroethyl)-N-nitroso-N′-2-hydroxyethylurea

HPC:

hexadecylphosphocholine

MNU:

methylnitrosourea

DMSO:

dimethylsulfoxide

IC50 :

50% inhibitory concentration

APC:

alkylphosphocholines

PBS:

phosphoate-buffered saline

fl:

femto litre

References

  1. Alley MC, Scudiero DA, Monks A, Hursey ML, Czerwinski MJ, Fine DL, Abbott BJ, Mayo JG, Shoemaker RH, Boyd R (1988) Feasibility of drug screening with panels of human tumor cell lines using a microculture tetrazolium assay. Cancer Res 48:589

    Google Scholar 

  2. Angres G, Scherf HR (1989) Different effects of cyclophosphamide in vivo and phosphamide mustard in vitro on two cell clones of chemically induced mammary carcinoma of the rat. J Cancer Res Clin Oncol 115:203

    Google Scholar 

  3. Baehner RL, Nathan DG (1968) Quantitative nitroblue tetrazolium test in chronic granulomatous disease. N Engl J Med 278:971

    Google Scholar 

  4. Berger MR, Muschiol C, Schmähl D, Eibl HJ (1987) New cytostatics with experimentally different toxic profiles. Cancer Treat Rev 14:307

    Google Scholar 

  5. Campling BG, Pym J, Baker HM, Cole SP, Lam YM (1991) Chemosensitivity testing of small cell lung cancer using the MTT assay. Br J Cancer 63:75

    Google Scholar 

  6. Carmichael J, DeGraff WG, Gazdar AF, Minna JD, Mitchell JB (1987) Evaluation of a tetrazolium-based semiautomated colorimetric assay: assessment of chemosensitivity testing. Cancer Res 47:936

    Google Scholar 

  7. Collins SJ, Ruscetti FW, Gallagher RE, Gallo RC (1979) Normal functional characteristics of cultured human promyelocytic leukemia cells (HL-60) after induction of differentiation by dimethylsulfoxide. J Exp Med 149:969

    Google Scholar 

  8. Comley JC, Rees J, Turner CH, Jenkins DC (1989) Colorimetric quantitation of filarial viability. Int J Parasitol 19:77

    Google Scholar 

  9. Day SR, Ziolkowski CHJ, Scudiero DA, Meyer SA, Lubiniecki AS, Girardi AJ, Galloway SM, Bynum GD (1980) Defective repair of alkylated DNA by human tumour and SV40-transformed human cell strains. Nature 288:724

    Google Scholar 

  10. Ferrari M, Fornasiero MC, Isetta AM (1990) MTT colorimetric assay for testing macrophage cytotoxicity activity in vitro. J Immunol Methods 131:165

    Google Scholar 

  11. Givens KT, Kitada S, Chen AK, Rothschiller J, Lee DA (1990) Proliferation of human ocular fibroblasts. An assessment of in vitro colorimetric assays. Invest Ophthalmol Vis Sci 31:1856

    Google Scholar 

  12. Goldin A, Venditti JM, MacDonald JS, Muggia FM, Henney JE, DeVita VT (1981) Current results of the screening program at the Division of Cancer Treatment, National Cancer Institute. Eur J Cancer 17:129

    Google Scholar 

  13. Guillem JG, Levy MF, Hsieh LL, Johnson MD, LoGerfo P, Forde KA, Weinstein IB (1990) Increased levels of phorbin, c-myc, and ornithine decarboxylase RNAs in human colon cancer. Mol Carcinog 3:68

    Google Scholar 

  14. Heo DS, Park JG, Hata K, Day R, Herberman RB, Whiteside TL (1990) Evaluation of tetrazolium-based semiautomatic colorimetric assay for measurement of human antitumor cytotoxicity. Cancer Res 50:3681

    Google Scholar 

  15. Hida T, Ueda R, Takahashi T, Watanabe H, Kato T, Suyama M, Sugiura T, Ariyoshi Y, Takahashi T (1989) Chemosensitivity and radiosensitivity of small cell lung cancer cell lines studied by a newly developed 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) hybrid assay. Cancer Res 49:4785

    Google Scholar 

  16. Hochhuth C, Berkovic D, Eibl HJ, Unger C, Doenecke D (1990) Effects of antineoplastic phospholipids on parameters of cell differentiation in U937 cells. J Cancer Res Clin Oncol 116:459

    Google Scholar 

  17. Hongo T, Fujii Y, Igarashi Y (1990) An in vitro chemosensitivity test for the screening of anti-cancer drugs in childhood leukemia. Cancer 65:1263

    Google Scholar 

  18. Jabbar SAB, Twentyman PR, Watson JV (1989) The MTT assay underestimates the growth inhibitory effects of interferons. Br J Cancer 60:523

    Google Scholar 

  19. Kaleagasioglu F, Berger MR, Schmähl D, Eisenbrand G (1990) In vitro evaluation of 1-(2-chloroethyl)-1-nitroso-3-(2-hydroxyethyl)urea linked to 4-acetoxybisdesmethyltamoxifen, estradiol and dihydrotestosterone. Arzneimittelforschung 40:603

    Google Scholar 

  20. Kasugai S, Hasegawa N, Ogura H (1991) Application of the MTT colorimetric assay to measure cytotoxic effects of phenolic compounds on established rat dental pulp cells. J Dent Res 70:127

    Google Scholar 

  21. Kirkpatrick DL, Duke M, Goh TS (1990) Chemosensitivity testing of fresh human leukemia cells using both a dye exclusion assay and a tetrazolium dye (MTT) assay. Leuk Res 14:459

    Google Scholar 

  22. Klebe RJ, Harriss JV (1984) A technically simple “non-lethal” vital staining procedure for viral plaque and cell transformation assays. Brief report. Arch Virol 81:359

    Google Scholar 

  23. Levitz SM, Diamond RD (1985) A rapid colorimetric assay of fungal viability with the tetrazolium salt MTT. J Infect Dis 152:938

    Google Scholar 

  24. Manthorpe M, Fagnani R, Skaper SD, Varon S (1986) An automated colorimetric microassay for neuronotrophic factors. Brain Res 390:191

    Google Scholar 

  25. Miller RR, Mc Devitt CA (1991) A quantitative microwell assay for chondrocyte cell adhesion. Anal Biochem 192:380

    Google Scholar 

  26. Mosmann T (1983) Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Methods 65:55

    Google Scholar 

  27. Muschiol C, Berger MR, Schuler B, Scherf HR, Garzon FT, Zeller WJ, Unger C, Eibl HJ, Schmähl D (1987) Alkyl phosphocholines: toxicity and anticancer properties. Lipids 22:930

    Google Scholar 

  28. Peck R (1985) A one-plate assay for macrophage bactericidal activity. J Immunol Methods 82:131

    Google Scholar 

  29. Pieters R, Huismains DR, Loonen AH, Hählen K, Van der Does van den Berg A, Van Wering ER, Veerman AJP (1990) Relation of cellular drug resistance to long-term clinical outcome in childhood acute lymphoblastic leukaemia. Lance 338:399

    Google Scholar 

  30. Pieters R, Loonen AH, Huismains DR, Broekema GJ, Diryen MWJ, Heyenbrok MW, Hählen K, Veerman AJP (1990) In vitro drug sensitivity of cells from children with leukemia using the MTT assay with improved culture conditions. Blood 76:2327

    Google Scholar 

  31. Plumb JA, Milroy R, Kaye SB (1989) Effects of the pH dependence of 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromideformazan absorption on chemosensitivity determined by a novel tetrazolium assay. Cancer Res 49:4435

    Google Scholar 

  32. Price P, McMillan TJ (1990) Use of the tetrazolium assay in measuring the response of human tumor cells to ionizing radiation. Cancer Res 50:1392

    Google Scholar 

  33. Ross DW (1976) Cell volume growth after cell cycle block with chemotherapeutic agents. Cell Tissue Kinet 9:379

    Google Scholar 

  34. Sargent JM, Taylor CG (1989) Appraisal of the MTT assay as a rapid test of chemosensitivity in acute myeloid leukaemia. Br J Cancer 60:206

    Google Scholar 

  35. Schmähl D, Berger MR (1988) Possibilities and limitations of antineoplastic chemotherapy: experimental and clinical aspects. Int J Exp Clin Chemother 1:1

    Google Scholar 

  36. Schneider SL, Fuqua SAW, Speeg KV, Tandon AK, McGuire WL (1990) Isolation and characterization of an Adriamycin-resistant breast tumor cell line. In Vitro Cell Dev Biol 26:621

    Google Scholar 

  37. Scudiero DA, Shoemaker RH, Paull KD, Monks A, Tierney S, Nofziger TH, Currens MJ, Seniff D, Boyd MR (1988) Evaluation of a soluble tetrazolium/formazan assay for cell growth and drug sensitivity in culture using human and other tumor cell lines. Cancer Res 48:4827

    Google Scholar 

  38. Sobottka SB, Berger MR (1991) Antitumor properties of octadecylphosphocholine (OPC),D 9-trans-oleylphosphocholine (t-OlPC) andD 9-cis-oleylphosphocholine (c-OlPC) in vitro. J Cancer Res Clin Oncol 117 [Suppl]:36

    Google Scholar 

  39. Überall F, Oberhuber H, Maly K, Zaknun J, Demuth L, Grunicke HH (1991) Hexadecylphosphocholine inhibits inositol phosphate formation and protein kinase C activity. Cancer Res 51:807

    Google Scholar 

  40. Van de Loosdrecht AA, Nennie E, Ossenkoppele GJ, Beelen RH, Langenhuijsen MM (1991) Cell mediated cytotoxicity against U 937 cells by human monocytes and macrophages in a modified colorimetric MTT assay. J Immunol Methods 141:15

    Google Scholar 

  41. Venditti JM (1981) Preclinical drug development: rationale and methods. Semin Oncol 8:349

    Google Scholar 

  42. Wassermann TH, Twentyman P (1988) Use of colorimetric microtiter (MTT) assay in determining the radiosensitivity of cells from murine solid tumors. Int J Radiat Oncol Biol Phys 15:699

    Google Scholar 

  43. Wei LL, Katzenellenbogen BS, Robertson DW, Simpson DM, Katzenellenbogen JA (1986) Nitrosourea and nitrosocarbamate derivatives of the antiestrogen tamoxifen as potential estrogen receptor-mediated cytotoxic agents in human breast cancer cells. Breast Cancer Res Treat 7:77

    Google Scholar 

  44. Weislow OS, Kiser R, Fine DL (1989) New soluble-formazan assay for HIV-1 cytopathic effects: application to high-flux screening of synthetic and natural products for AIDS-antiviral activity. J Natl Cancer Inst 81:577

    Google Scholar 

  45. Wilson JK, Sargent JM, Elgie AW, Hill JG, Taylor CG (1990) A feasibility study of the MTT assay for chemosensitivity testing in ovarian malignancy. Br J Cancer 62:189

    Google Scholar 

  46. Zeller WJ, Berger MR (1984) Chemically induced autochthonous tumor models in experimental chemotherapy. Behring Inst Mitt 74:201

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Institute of Toxicology and Chemotherapy, German Cancer Research Center, Im Neuenheimer Feld 280, D-6900, Heidelberg, Federal Republik of Germany

    Stephan B. Sobottka & Martin R. Berger

Authors
  1. Stephan B. Sobottka
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Martin R. Berger
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Sobottka, S.B., Berger, M.R. Assessment of antineoplastic agents by MTT assay: partial underestimation of antiproliferative properties. Cancer Chemother. Pharmacol. 30, 385–393 (1992). https://doi.org/10.1007/BF00689967

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00689967

Keywords

Search

Navigation